Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot Sells 5,381 Shares

Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot sold 5,381 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $41.64, for a total value of $224,064.84. Following the completion of the sale, the director now directly owns 319,752 shares in the company, valued at $13,314,473.28. This trade represents a 1.66 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Pro-Dex Trading Up 1.3 %

Shares of PDEX opened at $41.79 on Wednesday. The stock’s 50-day moving average price is $47.75 and its 200 day moving average price is $34.11. The company has a quick ratio of 1.94, a current ratio of 3.41 and a debt-to-equity ratio of 0.36. The firm has a market capitalization of $136.24 million, a price-to-earnings ratio of 27.14 and a beta of 0.56. Pro-Dex, Inc. has a 12-month low of $16.18 and a 12-month high of $59.60.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Ascendiant Capital Markets raised their price objective on shares of Pro-Dex from $30.00 to $52.00 and gave the stock a “buy” rating in a research note on Monday, November 11th. StockNews.com upgraded shares of Pro-Dex from a “buy” rating to a “strong-buy” rating in a research report on Saturday, December 14th.

Institutional Trading of Pro-Dex

Institutional investors and hedge funds have recently modified their holdings of the company. Ritholtz Wealth Management bought a new position in Pro-Dex in the fourth quarter worth $572,000. JPMorgan Chase & Co. raised its stake in shares of Pro-Dex by 2.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 24,790 shares of the medical instruments supplier’s stock valued at $740,000 after buying an additional 529 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Pro-Dex by 9.1% in the 3rd quarter. Geode Capital Management LLC now owns 27,435 shares of the medical instruments supplier’s stock valued at $819,000 after buying an additional 2,296 shares in the last quarter. FMR LLC lifted its holdings in shares of Pro-Dex by 34.9% during the 3rd quarter. FMR LLC now owns 3,973 shares of the medical instruments supplier’s stock worth $119,000 after acquiring an additional 1,028 shares during the period. Finally, Bard Associates Inc. boosted its position in shares of Pro-Dex by 17.6% during the 3rd quarter. Bard Associates Inc. now owns 13,596 shares of the medical instruments supplier’s stock valued at $406,000 after acquiring an additional 2,031 shares in the last quarter. 15.28% of the stock is currently owned by institutional investors.

About Pro-Dex

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.